Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference67 articles.
1. Bacha OM, Levesque E, Renaud MC, Lalancette M (2011) A case of recurrent vulvar carcinoma treated with erlotinib, an EGFR inhibitor. Eur J Gynaecol Oncol 32(4):423–424
2. Blandino G, Di Agostino S. New therapeutic strategies to treat human cancers expressing mutant p53 proteins. J Exp Clin Cancer Res CR [Internet]. 2018 Feb 15 [cited 2018 Jul 12], p. 37. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815234/
3. Brustmann H (2007) Epidermal growth factor receptor is involved in the development of an invasive phenotype in vulvar squamous lesions, but is not related to MIB-1 immunoreactivity. Int J Gynecol Pathol 26(4):481–489
4. Cancer Stat Facts (2017) Vulvar cancer. https://seer.cancer.gov/statfacts/html/vulva.html
5. Cao H, Wang S, Zhang Z, Lou J (2016) Prognostic value of overexpressed p16INK4a in vulvar cancer: a meta-analysis. PLoS ONE 11(3):e0152459
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献